|

Liraglutide Pen Injector Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Liraglutide

Pipeline

Phase 2: 1

Top Sponsors

  • Mayo Clinic1

Indications

  • Type 1 Diabetes1
  • Diabetes1
  • Type 2 Diabetes1

Rochester, Minnesota1 trial

The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes

Mayo Clinic in Rochester

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.